Simpson Thacher is representing Sheridan Healthcare and its controlling equityholders, investment funds affiliated with Hellman & Friedman LLC, in connection with Sheridan Healthcare’s pending sale to AmSurg Corp. (NASDAQ: AMSG) in a cash and stock transaction valued at $2.35 billion. The transaction is subject to customary closing conditions and regulatory approvals and is expected to close in the third quarter of 2014.
Sheridan Healthcare is a leading provider of multi-specialty outsourced physician services to hospitals, ambulatory surgery centers and other healthcare facilities, primarily in the areas of anesthesiology, children’s services emergency medicine, and radiology. AmSurg acquires, develops and operates ambulatory surgery centers in partnership with physician practice groups throughout the United States.
The Simpson Thacher team who worked on the transaction included: Chad Skinner, Atif Azher, Alexis Orenstein, Dena Acevedo, David Ray, Karen Reyes and Fred De Albuquerque (M&A); William Brentani (Capital Markets); Brian Steinhardt and Dan Kay (Credit); Katharine Moir and Judy Yan (Tax); David Rubinsky, Linda Barrett and Eric Wolf (Executive Compensation and Employee Benefits); Joshua Walker, Michelle Morad and Linda Nyberg (Intellectual Property); and Michael Isby (Environmental).
